EyePoint, Inc. short interest in 2020
In 2020, EyePoint, Inc.'s disclosed short interest ran from 7.80% of shares outstanding on 15 Jan 2020 to 1.46% on 30 Nov 2020, a change of -6.34 percentage points. The year's high was 7.80% on 15 Jan 2020 and its low 1.46% on 30 Nov 2020, averaging 2.88% across 22 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 25.81 days on 15 Jan 2020. Full history: EyePoint, Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2020 in figures
- Start of year
- 7.80% (15 Jan 2020)
- End of year
- 1.46% (30 Nov 2020)
- Change
- -6.34 pp
- High
- 7.80% (15 Jan 2020)
- Low
- 1.46% (30 Nov 2020)
- Average
- 2.88%
- Highest days to cover
- 25.81 (15 Jan 2020)
- SEC filings marked
- 10
Every report in 2020
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2020 | 7.80% | 25.81 | |
| 31 Jan 2020 | 7.43% | 10.24 | results (8-K) |
| 14 Feb 2020 | 6.94% | 22.82 | |
| 28 Feb 2020 | 3.88% | 2.45 | |
| 13 Mar 2020 | 3.16% | 4.08 | results (8-K) |
| 31 Mar 2020 | 2.47% | 5.08 | 10-K filed |
| 15 Apr 2020 | 2.26% | 4.03 | |
| 30 Apr 2020 | 2.33% | 10.14 | |
| 15 May 2020 | 2.52% | 8.47 | results (8-K), 10-Q filed |
| 29 May 2020 | 2.29% | 8.10 | |
| 15 Jun 2020 | 3.61% | 7.14 | |
| 30 Jun 2020 | 2.15% | 1.00 | |
| 15 Jul 2020 | 1.75% | 5.71 | |
| 31 Jul 2020 | 1.59% | 5.63 | |
| 14 Aug 2020 | 1.54% | 2.95 | 10-Q filed, results (8-K) |
| 31 Aug 2020 | 1.76% | 1.00 | |
| 15 Sep 2020 | 1.69% | 2.70 | |
| 30 Sep 2020 | 1.76% | 4.30 | |
| 15 Oct 2020 | 1.63% | 1.14 | results (8-K) |
| 30 Oct 2020 | 1.64% | 1.24 | |
| 13 Nov 2020 | 1.65% | 3.05 | results (8-K), 10-Q filed |
| 30 Nov 2020 | 1.46% | 1.22 |
See also: EyePoint, Inc.'s full history · most shorted US stocks of 2020 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.